Understanding Your Pharmacogenomics Report
MyOme Personal Genome Pharmacogenomic Report gives a healthcare provider additional information to help guide drug treatment selection. We recommended you discuss your results with your provider. Frequently asked questions can be found below.
Frequently Asked Questions
An individual’s response to medication can be impacted by their physical characteristics (weight, sex, age), their lifestyle (diet, exercise levels), their overall health (other diseases, kidney/liver issues), their genetics, and other medications or supplements they take. Your healthcare provider will consider these factors when determining what medication is best for you.
Your genetics can impact how you respond to medication by changing how your body breaks down and processes the drug (pharmacokinetics) and/or how well the drug is able to interact with your body (pharmacodynamics). The study and understanding of interactions between your genetics and a drug or drug(s) is pharmacogenomics. While genetics can have large effects on an individual’s response to medication, it is only one of many factors that influences how an individual might respond.
You should always consult your healthcare provider prior to making any changes to your medication regimen. Whenever a drug is prescribed, your healthcare provider weighs the benefits and risks associated with that prescription. Your genetics are only one piece of that decision process.
This report is limited only to pharmacogenomic information, which is only one component of the information your healthcare provider will use to determine the best course of treatment. Since MyOme does not know all these factors when it provides a report, we do not include drug level guidance in your report.
The FDA, the Clinical Pharmacogenetics Implementation Consortium (CPIC), and PharmGKB provide information about how to interpret pharmacogenomic test results in the context of specific medications.
More information can be found below:
